From Targets to candidates: Emerging Strategies in Drug Discovery

12 December 2013

New drug discovery strategies, facilitated by technological advances, have evolved rapidly in recent years. Drug researchers are now pushing the drug discovery envelope, particularly in the fields of hit identification, prosecution of new targets and exploration of novel chemical space.

This meeting brings together experts to highlight several of these developments describing work from hit identification through to candidate selection and beyond. Themes covered include the application of fragment based drug discovery to new target classes, antibodies in drug discovery, defining new chemical space with macrocycles and non-macrocycles, the renewed importance of phenotypic screening and approaches for the identification of allosteric modulators. The meeting will be of great interest to all involved in cutting edge drug discovery.

The National Heart and Lung Institute, Kensington, London